Simplify Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Simplify Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,135	Closed	-$1.18M	–	87
2022 Q3	$1.18M	Buy	19,135 +5,975	+45%	+$417K	0.13%	38
2022 Q2	$1.05M	Buy	13,160 +2,629	+25%	+$249K	0.04%	38
2022 Q1	$1.11M	Buy	10,531 +6,835	+185%	+$666K	0.04%	32
2021 Q4	$398K	Buy	+3,696	New	+$403K	0.02%	52

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Simplify Asset Management's HZNP Position: Q4 2022 in Review

Simplify Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 19,135 shares — an estimated $1.18M sold.

Simplify Asset Management first reported a position in HZNP in Q4 2021 and held it in 4 quarters. The position peaked at $1.18M in Q3 2022. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Simplify Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Simplify Asset Management sold 19,135 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.18M.
Simplify Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 4 quarters.
Simplify Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.18M in Q3 2022.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Simplify Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.